L-DOPA TREATMENT IN PARKINSONS DISEASE

被引：38
作者：
RINNE, UK
SONNINEN, V
SIIRTOLA, T
机构：
来源：
EUROPEAN NEUROLOGY | 1970年 / 4卷 / 06期
关键词：
D O I：
10.1159/000113990
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：348 / &
相关论文
共 71 条
[1]   EFFECTS OF L-DOPA IN TREATMENT OF PARKINSONIAN AKINESIA [J].
AEBERT, K .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1967, 92 (11) :483-+
[2]   EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE [J].
ANDEN, NE ;
RUBENSON, A ;
FUXE, K ;
HOKFELT, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) :627-&
[3]  
ANDEN NE, 1963, LIFE SCI, V2, P448
[4]  
ANDRESEN JA, 1958, SCIENCE, V127, P236
[5]  
BARBEAU A, 1969, CAN MED ASSOC J, V101, P791
[6]  
BARBEAU A, 1962, CATECHOLAMINES MALAD, P247
[7]  
BARBEAU A, 1961, 7 P INT C NEUR ROM, V2, P925
[8]   ON ORIGIN OF HOMOVANILLIC ACID IN CEREBROSPINAL FLUID [J].
BARTHOLI.G ;
PLETSCHE.A ;
TISSOT, R .
EXPERIENTIA, 1966, 22 (09) :609-&
[9]   DECREASE OF CEREBRAL 5-HYDROXYTRYPTAMINE BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF EXTRACEREBRAL DECARBOXYLASE [J].
BARTHOLINI, G ;
DAPRADA, M ;
PLETSCHER, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (03) :228-+
[10]  
BARTHOLINI G, 1968, J PHARMACOL EXP THER, V161, P14
12345678